Sign In
Buy SVA
$6.47
+0 (+0%)
At Close: Feb 07, 2020
SINOVAC Reports Unaudited and Unreviewed Second Half of 2025 Financial Results and Files 2025 Annual Report on Form 20-F
04:01pm, Friday, 05'th Jun 2026
BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced it filed its annual report
SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report
04:01pm, Friday, 29'th May 2026
BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notific
SINOVAC Announces Extension of Deadline to Submit Payment Instructions for Previously Declared Special Cash Dividend
06:30am, Thursday, 21'st May 2026
BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it has extended the d
SINOVAC Reports Unaudited First Half of 2025 Financial Results
05:00pm, Friday, 08'th May 2026
BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, announced today its unaudited financial re
SINOVAC Files Annual Report on Form 20-F for the Fiscal Year 2024
09:22am, Thursday, 30'th Apr 2026
BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it filed its annual r
SINOVAC Announces Nasdaq Hearings Panel Grants Continued Listing
06:00am, Thursday, 22'nd Jan 2026
BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that the Nasdaq Hearings P
SINOVAC Provides Update on Antigua High Court Order and Auditor Engagement
10:13am, Sunday, 04'th Jan 2026
BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today provided an update on the Antigua Hi
Sinovac Receives Nasdaq Notification Regarding Late Filing of 2025 Half-Year Report
10:00am, Sunday, 04'th Jan 2026
BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it has received a not
Sinovac: Antigua Court Makes Interim Order Giving Board Control of the Company until the Trial of the Disputed 2025 Shareholder Meeting
07:00am, Wednesday, 17'th Dec 2025
BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (NASDAQ: SVA) (SINOVAC or the Company), a leading provider of biopharmaceutical products in China, today announced that the Antigua High Court has ordere
SINOVAC Announces Receipt of Nasdaq Notice of Delisting and Intention to Appeal
03:00pm, Tuesday, 18'th Nov 2025
BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, announced today that on November 12, 2025,
Independent Sinovac Shareholders Express Strong Support for Immediate Dividend Payment
05:00pm, Tuesday, 11'th Nov 2025
BOSTON , Nov. 11, 2025 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) shareholder Heng Ren Silk Road Investments LLC today announced that it has heard from more than 100 independent Sinovac
SINOVAC Announces Appointment of Independent Auditor
10:30am, Friday, 24'th Oct 2025
BEIJING--(BUSINESS WIRE)--The Board of Directors and Management of SINOVAC Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, t
SINOVAC Board Sets the Record Straight on July 8 Special Meeting of Shareholders
04:21pm, Friday, 11'th Jul 2025
BEIJING--(BUSINESS WIRE)--The Board of Directors of SINOVAC Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”) today issued the following update to set the record straight regarding the S
Newly Elected Directors of Sinovac Hold the First Board Meeting
07:23am, Thursday, 10'th Jul 2025
BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (NASDAQ: SVA) (SINOVAC or the Company), a leading provider of biopharmaceutical products in China, today announced the new board of directors of the Comp
SINOVAC Board of Directors Strongly Denounces Deceptive and Illegal Claims by SAIF and the Imposter Former Board
12:34pm, Wednesday, 09'th Jul 2025
BEIJING--(BUSINESS WIRE)--The Board of Directors of SINOVAC Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading biopharmaceutical company in China, categorically rejects the rec
